Overview
Anna Einarsdottir practices practicing medicine in Reykjavik, Iceland.
Her clinical expertise encompasses Optic Neuritis, Retinal Vein Occlusion, and Multiple Sclerosis (MS).
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anna B. Einarsdottir
Is Anna B. Einarsdottir a top-rated expert for Optic Neuritis?
MediFind is an objective health platform that identifies experts based on real-world data. Anna B. Einarsdottir is classified as an Experienced expert for Optic Neuritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anna B. Einarsdottir participate in research or clinical trials?
Yes. Anna B. Einarsdottir has published 8 articles and abstracts on conditions like Optic Neuritis. You can view a list of Anna B. Einarsdottir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Multiple Sclerosis (MS)Ms. Einarsdottir isExperienced. Learn about Multiple Sclerosis (MS).
- Optic NeuritisMs. Einarsdottir isExperienced. Learn about Optic Neuritis.
- Retinal Vein OcclusionMs. Einarsdottir isExperienced. Learn about Retinal Vein Occlusion.